Trial Profile
Phase II study of single-agent Alimta [pemetrexed] in the treatment of patients with advanced and metastatic hepatoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2006
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 03 Aug 2006 Status change
- 05 Nov 2005 New trial record.